Početna › Veliki depresivni poremećaj › Alabama
Kliničke studije za Veliki depresivni poremećaj u državi Alabama
15 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- University of Alabama at Birmingham - School of Medicine, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Alabama at Birmingham, Huntsville
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05850689A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- UAB Psychiatry and Behavioral Neurology, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Alabama at Birmingham - Dept. of Psychiatry, Birmingham
U tijeku regrutacija
Od 22 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06423430Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. kol 2026. · NCT07226232NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06547489Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 10 do 24 godina · Oba spola · Ažurirano 13. srp 2026. · NCT05437588A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Harmonex /ID# 277517, Dothan
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. lip 2026. · NCT07276997MicroRNA Correlates of Childhood Maltreatment and Suicidality
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 60 godina · Oba spola · Ažurirano 30. ožu 2026. · NCT04923685Using TMS to Understand Neural Processes of Social Motivation
- Auburn University, Auburn
U tijeku regrutacija
Od 25 do 50 godina · Oba spola · Ažurirano 3. ožu 2026. · NCT06274112Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #131, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 20. sij 2026. · NCT06633016Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.